Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ProTreatment Svinninge ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   2.2% 2.5% 2.5% 2.4% 2.7% 2.3% 7.7% 7.7%   Credit score (0-100)   68 64 63 62 59 64 32 32   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,192 1,591 908 907 694 1,015 0.0 0.0   EBITDA   918 1,305 666 576 343 693 0.0 0.0   EBIT   705 1,106 468 377 147 501 0.0 0.0   Pre-tax profit (PTP)   654.4 1,077.2 433.2 368.9 142.0 485.7 0.0 0.0   Net earnings   506.3 839.7 337.6 287.1 110.6 378.8 0.0 0.0   Pre-tax profit without non-rec. items   654 1,077 433 369 142 486 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   33.6 25.3 17.0 8.7 1.8 0.0 0.0 0.0   Shareholders equity total   587 921 419 376 207 486 55.9 55.9   Interest-bearing liabilities   971 231 1,189 1,097 1,409 1,408 576 576   Balance sheet total (assets)   1,928 1,767 2,147 2,007 2,058 2,545 632 632   Net Debt   959 218 1,183 963 943 267 576 576     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,192 1,591 908 907 694 1,015 0.0 0.0   Gross profit growth   8.5% 33.4% -42.9% -0.1% -23.4% 46.2% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,928 1,767 2,147 2,007 2,058 2,545 632 632   Balance sheet change%   103.0% -8.4% 21.5% -6.5% 2.6% 23.6% -75.1% 0.0%   Added value   917.7 1,304.7 666.4 575.7 344.9 693.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   693 -397 -397 -397 -394 -384 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   59.2% 69.6% 51.6% 41.6% 21.1% 49.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   49.0% 59.9% 23.9% 18.2% 7.2% 21.8% 0.0% 0.0%   ROI %   61.2% 76.2% 30.5% 21.7% 8.4% 26.2% 0.0% 0.0%   ROE %   91.5% 111.4% 50.4% 72.2% 37.9% 109.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   30.4% 52.1% 19.5% 18.8% 10.1% 19.1% 8.8% 8.8%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   104.5% 16.7% 177.6% 167.3% 274.5% 38.5% 0.0% 0.0%   Gearing %   165.5% 25.0% 283.5% 291.4% 680.5% 289.7% 1,031.6% 1,031.6%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   9.2% 4.9% 4.9% 0.7% 0.4% 1.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.2 0.5 0.6 0.7 0.7 1.0 0.0 0.0   Current Ratio   0.2 0.5 0.6 0.7 0.7 1.0 0.0 0.0   Cash and cash equivalent   12.2 12.5 5.7 133.9 466.4 1,141.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -970.1 -383.5 -628.7 -425.9 -438.1 -9.1 -288.2 -288.2   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   918 1,305 666 576 345 693 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   918 1,305 666 576 343 693 0 0   EBIT / employee   705 1,106 468 377 147 501 0 0   Net earnings / employee   506 840 338 287 111 379 0 0